大葉大學圖書館 |

Extremophilic cyanobacteria for novel drug development[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.32939
書名/作者:	Extremophilic cyanobacteria for novel drug development/ by Sikha Mandal, Jnanendra Rath.
作者:	Mandal, Sikha.
其他作者:	Rath, Jnanendra.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	vii, 92 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Cyanobacteria - Therapeutic use.
標題:	Drug development.
標題:	Pharmaceutical microbiology.
標題:	Extreme environments - Microbiology.
標題:	Microbial metabolites.
標題:	Biomedicine.
標題:	Pharmaceutical Sciences/Technology.
ISBN:	9783319120096 (electronic bk.)
ISBN:	9783319120089 (paper)
內容註:	1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
摘要、提要註:	This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
電子資源:	http://dx.doi.org/10.1007/978-3-319-12009-6

Extremophilic cyanobacteria for novel drug development[electronic resource] /
Mandal, Sikha.

Extremophilic cyanobacteria for novel drug development[electronic resource] /by Sikha Mandal, Jnanendra Rath. - Cham :Springer International Publishing :2015. - vii, 92 p. :ill., digital ;24 cm. - SpringerBriefs in pharmaceutical science & drug development,1864-8118. - SpringerBriefs in pharmaceutical science & drug development..

1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.

This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.

ISBN: 9783319120096 (electronic bk.)

Standard No.: 10.1007/978-3-319-12009-6doiSubjects--Topical Terms:

604941
Cyanobacteria
--Therapeutic use.

LC Class. No.: QR46.5 / .M36 2015

Dewey Class. No.: 615.32939

Extremophilic cyanobacteria for novel drug development[electronic resource] /
LDR:02566nam a2200325 a 4500 001 425704
003 DE-He213
005 20150724132457.0
006 m d
007 cr nn 008maaau
008 151119s2015 gw s 0 eng d
020 $a 9783319120096 (electronic bk.)
020 $a 9783319120089 (paper)
024 7 $a 10.1007/978-3-319-12009-6 $2 doi
035 $a 978-3-319-12009-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR46.5 $b .M36 2015
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.32939 $2 23
090 $a QR46.5 $b .M271 2015
100 1 $a Mandal, Sikha. $3 604939
245 1 0 $a Extremophilic cyanobacteria for novel drug development $h [electronic resource] / $c by Sikha Mandal, Jnanendra Rath.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a vii, 92 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in pharmaceutical science & drug development, $x 1864-8118
505 0 $a 1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
520 $a This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
650 0 $a Cyanobacteria $x Therapeutic use. $3 604941
650 0 $a Drug development. $3 339189
650 0 $a Pharmaceutical microbiology. $3 561971
650 0 $a Extreme environments $x Microbiology. $3 464380
650 0 $a Microbial metabolites. $3 604942
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Pharmaceutical Sciences/Technology. $3 464319
700 1 $a Rath, Jnanendra. $3 604940
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in pharmaceutical science & drug development. $3 464325
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-12009-6
950 $a Medicine (Springer-11650)